Announcement

Collapse
No announcement yet.

Research Articles Abstract - 2012 Issues Archive

Collapse
X
  • Filter
  • Time
  • Show
Clear All
new posts

  • #46
    Research Articles Abstracts – November 10 2012 Issue

    [Source: AMEDEO, homepage: (LINK).]

    Research Articles Abstracts – November 10 2012 Issue



    This week’s abstracts:
    1. Xu J, Yang D, Huang D, Xu J, et al.
      • Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    2. El Moussi A, Ledesma J, Ben Hadj Kacem MA, Pozo F, et al.
      • Haemagglutinin D222G mutation found in a fatal case of pandemic (H1N1) flu in Tunisia.
    3. Fujisaki S, Takashita E, Yokoyama M, Taniwaki T, et al.
      • A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
    4. Tran AT, Cortens JP, Du Q, Wilkins JA, et al.
      • Influenza Virus Induces Apoptosis via BAD-mediated Mitochondria Dysregulation.
    5. Banyai K, Kovacs E, Toth AG, Biksi I, et al.
      • Genome Sequence of a Monoreassortant H1N1 Swine Influenza Virus Isolated from a Pig in Hungary.
    6. Watanabe T, Imai M, Watanabe S, Shinya K, et al.
      • Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients.
    7. Kulkarni PS, Manjunath K, Agarkhedkar S.
      • Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children.
    8. Schwarz TF, Schmoele-Thoma B.
      • Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged >/=65 years.
    9. Shinjo SK, de Moraes JC, Levy-Neto M, Aikawa NE, et al.
      • Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease.
    10. Gorman JR, Brewer NT, Wang JB, Chambers CD, et al.
      • Theory-based predictors of influenza vaccination among pregnant women.
    11. Gong M, Zhou J, Yang C, Deng Y, et al.
      • Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate.
    12. Landelle C, Vanhems P, Saadatian-Elahi M, Voirin N, et al.
      • Influenza vaccination coverage among patients and healthcare workers in a university hospital during the 2006-2007 influenza season.
    13. Plant EP, Liu TM, Xie H, Ye Z, et al.
      • Mutations to A/Puerto Rico/8/34 PB1 gene improves seasonal reassortant influenza A virus growth kinetics.
    14. Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, et al.
      • Immunization coverage and timeliness of vaccination in Italian children with chronic diseases.
    15. Beato MS, Mancin M, Yang J, Buratin A, et al.
      • Antigenic characterization of recent H5N1 highly pathogenic avian influenza viruses circulating in Egyptian poultry.
    16. Mansbach JM, Piedra PA, Stevenson MD, Sullivan AF, et al.
      • Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.
    17. Perwitasari O, Yan X, Johnson S, White C, et al.
      • Targeting the Organic Anion Transporter-3 (OAT3) with Probenecid as a Novel Anti-Influenza A Virus Strategy.
    -
    --------

    Comment


    • #47
      Research Articles Abstracts–November 17 2012 Issue

      [Source: AMEDEO, homepage: (LINK).]

      Research Articles Abstracts–November 17 2012 Issue



      This week’s abstracts:
      1. Alby K, Popowitch EB, Miller MB.
        • Comparative evaluation of the Nanosphere Verigene RV+ Assay with the Simplexa Flu A/B & RSV Kit for the detection of influenza and respiratory syncytial viruses.
      2. Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, et al.
        • Human T cells directed to seasonal influenza A virus cross-react with A(H1N1)pdm09 and swine origin triple reassortant H3N2 influenza viruses.
      3. Nayak JL, Fitzgerald TF, Richards KA, Yang H, et al.
        • CD4 T-cell expansion predicts neutralizing antibody responses to monovalent inactivated pandemic H1N1 influenza vaccine.
      4. Wu NC, Young AP, Dandekar S, Wijersuriya H, et al.
        • Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening.
      5. Cline TD, Karlsson EA, Seufzer BJ, Schultz-Cherry S, et al.
        • The Hemagglutinin Protein of Highly Pathogenic H5N1 Influenza Viruses Overcomes an Early Block in the Replication Cycle to Promote Productive Replication in Macrophages.
      6. Matzinger SR, Carroll TD, C Dutra J, Ma ZM, et al.
        • Myxovirus resistance gene A (MxA) expression suppresses Influenza A virus replication in Interferon-alpha stimulated primate cells.
      7. Partridge J, Kieny MP.
        • Global production capacity of seasonal influenza vaccine in 2011.
      8. Drees M, Tambourelli B, Denstman A, Zhang W, et al.
        • Sustained high influenza vaccination rates and decreased safety concerns among pregnant women during the 2010-2011 influenza season.
      9. Chang YC, Huang N, Chen LS, Hsu SW, et al.
        • Factors affecting repeated influenza vaccination among older people in Taiwan.
      10. Hernandez-Garcia I, Dominguez B, Gonzalez R.
        • Influenza vaccination rates and determinants among Spanish medical students.
      11. Diazgranados CA, Denis M, Plotkin S.
        • Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials.
      -
      --------

      Comment


      • #48
        Research Articles Abstracts – November 24 2012 Issue

        [Source: AMEDEO, homepage: (LINK).]

        Research Articles Abstracts – November 24 2012 Issue



        This week’s abstracts:
        1. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, et al.
          • miR-451 Regulates Dendritic Cell Cytokine Responses to Influenza Infection.
        2. Sundling C, Murillo PM, Soldemo M, Spangberg M, et al.
          • Immunization of macaques with soluble HIV-1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B cell responses after boosting.
        3. Hu Y, Liu X, Li S, Guo X, et al.
          • Complete Genome Sequence of a Novel H4N1 Influenza Virus Isolated from a Pig in Central China.
        4. Zou W, Guo X, Li S, Yang Y, et al.
          • Complete Genome Sequence of a Novel Natural Recombinant H5N5 Influenza Virus from Ducks in Central China.
        5. Xie Z, Xie L, Zhou C, Liu J, et al.
          • Complete Genome Sequence Analysis of an H6N1 Avian Influenza Virus Isolated from Guangxi Pockmark Ducks.
        6. Wang N, Zou W, Yang Y, Guo X, et al.
          • Complete Genome Sequence of an H10N5 Avian Influenza Virus Isolated from Pigs in Central China.
        7. Zhao S, Suo L, Jin M.
          • Genetic Characterization of a Novel Recombinant H5N2 Avian Influenza Virus Isolated from Chickens in Tibet.
        8. Okamatsu M, Feng F, Ohyanagi T, Nagahori N, et al.
          • Fluorescence polarization-based assay using N-glycan-conjugated quantum dots for screening in hemagglutinin blockers for influenza A viruses.
        9. Lorieau JL, Louis JM, Schwieters CD, Bax A, et al.
          • pH-triggered, activated-state conformations of the influenza hemagglutinin fusion peptide revealed by NMR.
        10. Wang IK, Lin CL, Chang YC, Lin PC, et al.
          • Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study.
        -
        -------

        Comment


        • #49
          Research Articles Abstracts–December 1st 2012 Issue

          [Source: AMEDEO, homepage: (LINK).]

          Research Articles Abstracts–December 1st 2012 Issue




          This week’s abstracts:
          • J Clin Microbiol
            • SU S , Qi W, Chen J, Zhu W, et al
              • Seroepidemiological Evidence of Avian Influenza A Virus Transmission to Pigs in Southern China.
          • J Infect Dis
            • BARAKAT A , Ihazmad H, El Falaki F, Tempia S, et al
              • 2009 Pandemic Influenza A Virus Subtype H1N1 in Morocco, 2009-2010: Epidemiology, Transmissibility, and Factors Associated With Fatal Cases.
            • LUTWAMA JJ , Bakamutumaho B, Kayiwa JT, Chiiza R, et al
              • Clinic- and hospital-based sentinel influenza surveillance, Uganda 2007-2010.
            • MMBAGA VM , Mwasekaga MJ, Mmbuji P, Matonya M, et al
              • Results from the first 30 months of national sentinel surveillance for influenza in Tanzania, 2008-2010.
            • NYATANYI T , Nkunda R, Rukelibuga J, Palekar R, et al
            • WONG KK , Bulimo WD, Magana J, Achilla RA, et al
              • Epidemiology of 2009 Pandemic Influenza A Virus Subtype H1N1 Among Kenyans Aged 2 Months to 18 Years, 2009-2010.
            • ONYANGO CO , Njeru R, Kazungu S, Achilla R, et al
              • Influenza surveillance among children with pneumonia admitted to a district hospital in coastal kenya, 2007-2010.
            • KATZ MA , Lebo E, Emukule G, Njuguna HN, et al
              • Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural kenya, 2007-2010.
            • HERAUD JM , Njouom R, Rousset D, Kadjo H, et al
              • Spatiotemporal circulation of influenza viruses in 5 african countries during 2008-2009: a collaborative study of the institut pasteur international network.
            • BULIMO WD , Achilla RA, Majanja J, Mukunzi S, et al
              • Molecular Characterization and Phylogenetic Analysis of the Hemagglutinin 1 Protein of Human Influenza A Virus Subtype H1N1 Circulating in Kenya During 2007-2008.
            • AYELE W , Demissie G, Kassa W, Zemelak E, et al
              • Challenges of establishing routine influenza sentinel surveillance in ethiopia, 2008-2010.
            • MUYEMBE TAMFUM JJ , Nkwembe E, Bi Shamamba SK, Bankoshi F, et al
              • Sentinel surveillance for influenza-like illness, severe acute respiratory illness, and laboratory-confirmed influenza in kinshasa, democratic republic of congo, 2009-2011.
            • NJOUOM R , Yekwa EL, Cappy P, Vabret A, et al
              • Viral etiology of influenza-like illnesses in cameroon, january-december 2009.
            • MIHIGO R , Torrealba CV, Coninx K, Nshimirimana D, et al
              • 2009 Pandemic Influenza A Virus Subtype H1N1 Vaccination in Africa--Successes and Challenges.
            • THEO A , Liwewe M, Ndumba I, Mupila Z, et al
            • VENTER M , Naidoo D, Pretorius M, Buys A, et al
              • Evolutionary Dynamics of 2009 Pandemic Influenza A Virus Subtype H1N1 in South Africa During 2009-2010.
            • MCANERNEY JM , Cohen C, Moyes J, Besselaar TG, et al
              • Twenty-five Years of Outpatient Influenza Surveillance in South Africa, 1984-2008.
            • ARCHER BN , Timothy GA, Cohen C, Tempia S, et al
              • Introduction of 2009 Pandemic Influenza A Virus Subtype H1N1 Into South Africa: Clinical Presentation, Epidemiology, and Transmissibility of the First 100 Cases.
            • ORELLE A , Razanajatovo NH, Rajatonirina S, Hoffmann J, et al
              • Epidemiological and Virological Characterization of 2009 Pandemic Influenza A Virus Subtype H1N1 in Madagascar.
            • RADIN JM , Katz MA, Tempia S, Talla Nzussouo N, et al
            • CARDOSO Y , Oliveira E, Vasconcelos J, Cohen AL, et al
              • Characteristics of Patients With Influenza-Like Illness, Severe Acture Respiratory Illness, and Laboratory-Confirmed Influenza at a Major Children's Hospital in Angola, 2009-2011.
            • NIANG MN , Dosseh A, Ndiaye K, Sagna M, et al
            • DALHATU IT , Medina-Marino A, Olsen SJ, Hwang I, et al
              • Influenza viruses in Nigeria, 2009-2010: results from the first 17 months of a national influenza sentinel surveillance system.
            • BONNEY JH , Kronmann KC, Lindan CP, Asante IA, et al
              • Virological surveillance of influenza-like illness among children in ghana, 2008-2010.
            • NZUSSOUO NT , Michalove J, Diop OM, Njouom R, et al
              • Delayed 2009 Pandemic Influenza A Virus Subtype H1N1 Circulation in West Africa, May 2009-April 2010.
            • KATZ MA , Schoub BD, Heraud JM, Breiman RF, et al
          • J Virol Methods
            • MORENO A , Lelli D, Brocchi E, Sozzi E, et al
              • Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses.
          • PLoS One
            • CHEN Z , Xu P, Salyards GW, Harvey SB, et al
              • Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5.
            • WU W , Zhang W, Booth JL, Metcalf JP, et al
              • Influenza A(H1N1)pdm09 Virus Suppresses RIG-I Initiated Innate Antiviral Responses in the Human Lung.
            • VAN BOECKEL TP , Thanapongtharm W, Robinson T, Biradar CM, et al
              • Improving Risk Models for Avian Influenza: The Role of Intensive Poultry Farming and Flooded Land during the 2004 Thailand Epidemic.
          • Proc Natl Acad Sci U S A
            • LEE CM , Weight AK, Haldar J, Wang L, et al
              • Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection.
            • SHAMAN J , Karspeck A
            • SCHMIDT AG , Xu H, Khan AR, O'Donnell T, et al
              • Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.
          • Vaccine
            • PARIS B , Arahood T, Asche C, Amundson G, et al
              • Voluntary reporting of health care personnel seasonal influenza vaccination rates and the impact of universal policies in Illinois hospitals.
            • ALLERSON M , Deen J, Detmer S, Gramer M, et al
              • The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populations.
            • CIBLAK MA
              • Influenza vaccination in Turkey: Prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate.
          -
          -------

          Comment


          • #50
            Research Articles Abstracts – December 8 2012 Issue

            [Source: AMEDEO, homepage: (LINK).]

            Research Articles Abstracts – December 8 2012 Issue




            This week’s abstracts:
            • J Immunol
              • HAMADA H , Bassity E, Flies A, Strutt TM, et al
            • J Infect Dis
              • AOKI FY , Hayden FG
                • The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-10 influenza A (H1N1) pandemic.
              • MUTHURI SG , Myles PR, Venkatesan S, Leonardi-Bee J, et al
                • Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-10 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.
              • HOCKE AC , Berg J, Becher A, Knepper J, et al
              • FUJINO N , Kubo H, Ota C, Suzuki T, et al
                • Increased severity of H1N1 pandemic influenza virus infection in alveolar type II cells from patients with pulmonary fibrosis.
            • J Virol
              • HARTMANN BM , Li W, Jia J, Patil S, et al
                • Mouse dendritic cell influenza virus infectivity is much lower than for human and is hemagglutinin subtype dependent.
              • BLANCO JC , Pletneva LM, Wan H, Araya Y, et al
                • Receptor Characterization and Susceptibility of Cotton Rats to Avian and 2009 Pandemic Influenza strains.
              • BARON J , Tarnow C, Mayoli-Nussle D, Schilling E, et al
              • KAMINSKI MM , Ohnemus A, Staeheli P, Rubbenstroth D, et al
                • Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model.
            • PLoS One
              • BIALAS KM , Desmet EA, Takimoto T
                • Specific Residues in the 2009 H1N1 Swine-Origin Influenza Matrix Protein Influence Virion Morphology and Efficiency of Viral Spread In Vitro.
              • HO TY , Huang KY, Huang TT, Huang YS, et al
                • The impact of influenza vaccinations on the adverse effects and hospitalization rate in the elderly: a national based study in an asian country.
              • DE LA ROSA-ZAMBONI D , Vazquez-Perez JA, Avila-Rios S, Carranco-Arenas AP, et al
                • Molecular Characterization of the Predominant Influenza A(H1N1)pdm09 Virus in Mexico, December 2011-February 2012.
              • SARNTIVIJAI S , Xiang Z, Shedden KA, Markel H, et al
                • Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.
              • RATANAKORN P , Wiratsudakul A, Wiriyarat W, Eiamampai K, et al
                • Satellite Tracking on the Flyways of Brown-Headed Gulls and Their Potential Role in the Spread of Highly Pathogenic Avian Influenza H5N1 Virus.
              • PLUMB AW , Patton DT, Seo JH, Loveday EK, et al
                • Interleukin-7, but not thymic stromal lymphopoietin, plays a key role in the T cell response to influenza a virus.
            • Vaccine
              • CHIU PJ , Chen CH, Chih YC
                • Effectiveness of the influenza vaccination program for the elderly in Taiwan.
              • BOYD AC , Ruiz-Hernandez R, Peroval MY, Carson C, et al
                • Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
              • DERHOVANESSIAN E , Theeten H, Hahnel K, Van Damme P, et al
                • Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination.
            -
            -------

            Comment


            • #51
              Research Articles Abstracts–December 15 2012 Issue

              [Source: AMEDEO, homepage: (LINK).]

              Research Articles Abstracts–December 15 2012 Issue




              This week’s abstracts:
              • Biochem Biophys Res Commun
                • ZHOU D , Mei Q, Li J, He H, et al
              • Epidemiol Infect
                • BOLLAERTS K , Antoine J, VAN Casteren V, Ducoffre G, et al
              • J Gen Virol
                • RAHIM MN , Selman M, Sauder P, Forbes NE, et al
                  • Generation and characterization of a new panel of broadly-reactive monoclonal anti-NS1 antibodies for detection of Influenza A virus.
              • J Immunol
                • LUCIANI F , Sanders MT, Oveissi S, Pang KC, et al
                  • Increasing Viral Dose Causes a Reversal in CD8+ T Cell Immunodominance during Primary Influenza Infection due to Differences in Antigen Presentation, T Cell Avidity, and Precursor Numbers.
                • WHEELER JL , Martin KC, Lawrence BP
                  • Novel Cellular Targets of AhR Underlie Alterations in Neutrophilic Inflammation and Inducible NO Synthase Expression during Influenza Virus Infection.
                • HUTTER J , Rodig JV, Hoper D, Seeberger PH, et al
                  • Toward Animal Cell Culture-Based Influenza Vaccine Design: Viral Hemagglutinin N-Glycosylation Markedly Impacts Immunogenicity.
                • ANDERSON KG , Sung H, Skon CN, Lefrancois L, et al
              • J Infect Dis
                • VIBOUD C , Eisenstein J, Reid AH, Janczewski TA, et al
                  • Age and gender mortality profileassociated with the 1918-19 influenza pandemic in Kentucky, USA.
                • KIMBERLIN DW , Acosta EP, Prichard MN, Sanchez PJ, et al
                  • Oseltamivir Pharmacokinetics, Dosing, and Resistance in Children From Birth to Two Years of Age with Influenza.
                • YPMA RJ , Jonges M, Bataille A, Stegeman A, et al
                  • Genetic data provide evidence for wind-mediated transmission of highly pathogenic avian influenza.
              • J Virol
                • LEON AJ , Banner D, Xu L, Ran L, et al
                • MURAMOTO Y , Noda T, Kawakami E, Akkina R, et al
                • DU L , Jin L, Zhao G, Sun S, et al
                  • Identification and Structural Characterization of a Broadly Neutralizing Antibody Targeting a Novel Conserved Epitope on Influenza H5N1 Hemagglutinin.
                • BUKREYEV A , Yang L, Collins PL
                  • The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement.
                • PINILLA LT , Holder BP, Abed Y, Boivin G, et al
                  • The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.
                • LUONGO C , Winter CC, Collins PL, Buchholz UJ, et al
                  • Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics.
                • YAMAGUCHI Y , Harker JA, Wang B, Openshaw PJ, et al
                  • Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.
                • PICA N , Langlois RA, Krammer F, Margine I, et al
                  • NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.
                • LIFLAND AW , Jung J, Alonas E, Zurla C, et al
                  • Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
                • WU W , Tran KC, Teng MN, Heesom KJ, et al
                  • The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.
              • MMWR Morb Mortal Wkly Rep
                  • Update: influenza activity - United States, september 30-november 24, 2012.
              • N Engl J Med
                • ANDERSON LJ , Baric RS
                • ZAKI AM , van Boheemen S, Bestebroer TM, Osterhaus AD, et al
              • Pediatrics
                • DIAZ PV , Pinto RA, Mamani R, Uasapud PA, et al
              • PLoS One
                • MARGINE I , Martinez-Gil L, Chou YY, Krammer F, et al
                  • Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.
                • LINIGER M , Summerfield A, Ruggli N
                  • MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens.
                • PIAGGIO AJ , Shriner SA, Vandalen KK, Franklin AB, et al
                  • Molecular Surveillance of Low Pathogenic Avian Influenza Viruses in Wild Birds across the United States: Inferences from the Hemagglutinin Gene.
                • CHAN RW , Leung CY, Nicholls JM, Peiris JS, et al
                  • Proinflammatory Cytokine Response and Viral Replication in Mouse Bone Marrow Derived Macrophages Infected with Influenza H1N1 and H5N1 Viruses.
                • ZHAO D , Liang L, Li Y, Jiang Y, et al
                  • Phylogenetic and Pathogenic Analyses of Avian Influenza A H5N1 Viruses Isolated from Poultry in Vietnam.
                • YANG P , Ma C, Shi W, Cui S, et al
                  • A Serological Survey of Antibodies to H5, H7 and H9 Avian Influenza Viruses amongst the Duck-Related Workers in Beijing, China.
                • SASAKI T , Kubota-Koketsu R, Takei M, Hagihara T, et al
                  • Reliability of a Newly-Developed Immunochromatography Diagnostic Kit for Pandemic Influenza A/H1N1pdm Virus: Implications for Drug Administration.
                • GILBERT M , Jambal L, Karesh WB, Fine A, et al
                • NI K , Li S, Xia Q, Zang N, et al
                  • Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection.
              • Proc Natl Acad Sci U S A
                • LIN YP , Xiong X, Wharton SA, Martin SR, et al
                  • Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.
              • Vaccine
                • GREENBERG DP , Robertson CA, Noss MJ, Blatter MM, et al
                  • Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
                • KING JC JR , Lichenstein R, Magder LS
                  • Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
                • STEWART AM , Cox MA
                • VALOUR F , Benet T, Chidiac C
                  • Pandemic A(H1N1)2009 influenza vaccination in Lyon University Hospitals, France: Perception and attitudes of hospital workers.
                • GARLAPATI S , Garg R, Brownlie R, Latimer L, et al
                  • Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.
              • Virology
                • OLDSTONE MB , Teijaro JR, Walsh KB, Rosen H, et al
                  • Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.
              -
              -------

              Comment


              • #52
                Research Articles Abstracts–December 22 2012 Issue

                [Source: AMEDEO, homepage: (LINK).]

                Research Articles Abstracts–December 22 2012 Issue




                This week’s abstracts:
                • Arch Virol
                  • GEN F , Yamada S, Kato K, Akashi H, et al
                    • Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice.
                • J Gen Virol
                  • RAN Z , Chen Y, Shen H, Xiang X, et al
                    • IN VITRO AND IN VIVO REPLICATION OF INFLUENZA A H1N1 WSN33 VIRUSES WITH DIFFERENT M1 PROTEINS.
                • J Infect Dis
                  • GARG S , Moore Z, Lee N, McKenna J, et al
                    • A Cluster of Patients Infected with I221V Influenza B Virus Variants with Reduced Oseltamivir Susceptibility--North Carolina and South Carolina, 2010-2011.
                • J Virol
                  • HU J , Hu Z, Song Q, Gu M, et al
                    • The PA gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice.
                  • SUN E , He J, Zhuang X
                  • ZENG H , Goldsmith C, Maines TR, Belser JA, et al
                    • Tropism and Infectivity of Influenza Virus, Including Highly Pathogenic Avian H5N1 Virus in Ferret Tracheal Differentiated Primary Epithelial Cell Cultures.
                  • RAMOS I , Carnero E, Bernal-Rubio D, Seibert CW, et al
                    • Contribution of dsRNA and CPSF30 Binding Domains of Influenza Virus NS1 to the Inhibition of Type I IFN Production and Activation of Human Dendritic Cells.
                • J Virol Methods
                  • WU L , Ding L, Pei Z, Huo X, et al
                    • A multiplex reverse transcription-PCR assay for the detection of influenza A virus and differentiation of the H1, H3, H5 and H9 subtypes.
                • Lancet
                  • KARESH WB , Dobson A, Lloyd-Smith JO, Lubroth J, et al
                • PLoS One
                  • LANDREAU F , Galeano P, Caltana LR, Masciotra L, et al
                    • Effects of two commonly found strains of influenza a virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.
                  • QI W , Tian J, Zhang C, He J, et al
                    • Potential Role of HPA Axis and Sympathetic Nervous Responses in Depletion of B Cells Induced by H9N2 Avian Influenza Virus Infection.
                  • DIMMOCK NJ , Dove BK, Scott PD, Meng B, et al
                    • Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza a virus and allows protective immunity to be established.
                  • NFON C , Berhane Y, Pasick J, Embury-Hyatt C, et al
                    • Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1.
                  • SUESS T , Remschmidt C, Schink SB, Schweiger B, et al
                    • Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007-2011.
                  • RAFIQ S , Russell ML, Webby R, Fonseca K, et al
                    • Serological Response to Influenza Vaccination among Children Vaccinated for Multiple Influenza Seasons.
                  • COUCH RB , Decker WK, Utama B, Atmar RL, et al
                    • Evaluations for in vitro correlates of immunogenicity of inactivated influenza a h5, h7 and h9 vaccines in humans.
                  • COUCH RB , Patel SM, Wade-Bowers CL, Nino D, et al
                • Vaccine
                  • ALVAREZ P , Zylberman V, Ghersi G, Boado L, et al
                    • Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice.
                  • PITMAN RJ , Nagy LD, Sculpher MJ
                    • Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.
                  • TACKEN MA , Jansen B, Mulder J, Visscher S, et al
                    • Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: A cohort study from 2009 to 2011.
                  • WIJNANS L , Lecomte C, de Vries C, Weibel D, et al
                    • The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
                  • SBIDIAN E , Tubach F, Pasquet B, Paul C, et al
                    • Factors associated with 2009 monovalent H1N1 vaccine coverage: A cross sectional study of 1308 patients with psoriasis in France.
                • Virus Res
                  • PATEL D , Schultz LW, Umland TC
                    • Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins.
                  • AWEYA JJ , Mak TM, Lim SG, Tan YJ, et al
                    • The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2.
                  • MADERA RF , Libraty DH
                    • The Role of MyD88 Signaling in Heterosubtypic Influenza A Virus Infections.
                -
                -------

                Comment


                • #53
                  Research Articles Abstracts–December 31 2012 Issue

                  [Source: AMEDEO, homepage: (LINK).]

                  Research Articles Abstracts–December 31 2012 Issue




                  This week’s abstracts:
                  • Antiviral Res
                    • LIU J , Chen P, Jiang Y, Deng G, et al
                      • Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection.
                    • WANG D , Sleeman K, Huang W, Nguyen HT, et al
                      • Neuraminidase Inhibitor Susceptibility Testing of Influenza Type B Viruses in China during 2010 and 2011 Identifies Viruses with Reduced Susceptibility to Oseltamivir and Zanamivir.
                  • J Virol
                    • CHEN Z , Zhou M, Gao X, Zhang G, et al
                      • A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
                    • SUN Y , Tan Y, Wei K, Sun H, et al
                      • Amino acid 316 of hemagglutinin and the neuraminidase stalk length influence virulence of H9N2 influenza virus in chickens and mice.
                  • J Virol Methods
                    • NGUYEN TT , Kwon HJ, Kim IH, Hong SM, et al
                      • Multiplex nested RT-PCR for detecting avian influenza virus, infectious bronchitis virus and Newcastle disease virus.
                    • TAKAYAMA I , Nakauchi M, Fujisaki S, Odagiri T, et al
                      • Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.
                  • Vaccine
                    • AMBROSE CS , Wu X
                      • The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults.
                    • DIAZGRANADOS CA , Dunning AJ, Jordanov E, Landolfi V, et al
                      • High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season.
                    • NARWANEY KJ , Glanz JM, Norris JM, Fingerlin TE, et al
                      • Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children.
                    • MURATA Y , Catherman SC
                      • Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.
                  -
                  -------

                  Comment


                  • #54
                    Research Articles Abstracts–January 5 2013 Issue

                    [Source: AMEDEO, homepage: (LINK).]

                    Research Articles Abstracts–January 5 2013 Issue




                    This week’s abstracts:
                    • Ann Intern Med
                      • MCKITTRICK N , Frank I, Jacobson JM, White CJ, et al
                        • Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-Infected Persons: A Single-Center, Parallel, Randomized Trial.
                    • Antiviral Res
                      • TUTYKHINA IL , Sedova ES, Gribova IY, Ivanova TI, et al
                        • Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection.
                      • LEANG SK , Deng YM, Shaw R, Caldwell N, et al
                        • Influenza antiviral resistance in the Asia-Pacific region during 2011.
                      • TILLIB SV , Ivanova TI, Vasilev LA, Rutovskaya MV, et al
                        • Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2).
                    • BMJ
                      • ARNHEIM-DAHLSTROM L , Hallgren J, Weibull CE, Sparen P, et al
                        • Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.
                    • J Clin Microbiol
                      • MCLEISH NJ , Witteveldt J, Clasper L, McIntyre C, et al
                        • Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real-time screening and typing methods.
                      • SCHIBLER M , Yerly S, Vieille G, Docquier M, et al
                        • Critical analysis of rhinovirus RNA load quantification by real-time reverse transcription-PCR.
                    • J Infect Dis
                      • GHEDIN E , Holmes EC, DePasse JV, Pinilla LT, et al
                        • Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.
                      • AGOTI CN , Mwihuri AG, Sande CJ, Onyango CO, et al
                        • Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya.
                    • J Virol
                      • JIANG W , Wang Q, Chen S, Gao S, et al
                        • Influenza A virus NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein.
                      • ROCKMAN S , Brown LE, Barr IG, Gilbertson B, et al
                        • Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza in ferrets immunised with seasonal influenza vaccine.
                      • DESMET EA , Bussey KA, Stone R, Takimoto T, et al
                        • Identification of the N-terminal domain of influenza PA responsible for the suppression of host protein synthesis.
                      • SIVAY MV , Baranovich T, Marchenko VY, Sharshov KA, et al
                      • BROOKE CB , Ince WL, Wrammert J, Ahmed R, et al
                      • COLPITTS CC , Ustinov AV, Epand RF, Epand RM, et al
                        • 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza, hepatitis C and other enveloped viruses.
                    • PLoS One
                      • MORNER A , Brave A, Kling AM, Kuhlmann-Berenzon S, et al
                        • Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009.
                      • SONG HO , Kim JH, Ryu HS, Lee DH, et al
                        • Polymeric LabChip Real-Time PCR as a Point-of-Care-Potential Diagnostic Tool for Rapid Detection of Influenza A/H1N1 Virus in Human Clinical Specimens.
                      • GUPTA V , Dawood FS, Muangchana C, Lan PT, et al
                      • JIANG W , Liu S, Hou G, Li J, et al
                      • WANG W , Huang B, Jiang T, Wang X, et al
                        • Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli.
                      • ZHAI W , Zhang DN, Mai C, Choy J, et al
                        • Comparison of different cell substrates on the measurement of human influenza virus neutralizing antibodies.
                      • LIU H , Patil HP, de Vries-Idema J, Wilschut J, et al
                        • Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100.
                      • GLATMAN-FREEDMAN A , Portelli I, Jacobs SK, Mathew JI, et al
                        • Attack Rates Assessment of the 2009 Pandemic H1N1 Influenza A in Children and Their Contacts: A Systematic Review and Meta-Analysis.
                      • VAN HELDEN MJ , Zaiss DM, Sijts AJ
                        • CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice.
                      • RHEDIN S , Hamrin J, Naucler P, Bennet R, et al
                        • Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden.
                    • Proc Natl Acad Sci U S A
                      • EISEN HN , Chakraborty AK
                        • Immunopaleontology reveals how affinity enhancement is achieved during affinity maturation of antibodies to influenza virus.
                    -
                    --------

                    Comment


                    • #55
                      Research Articles Abstract - 2012 Issues Archive

                      This thread contains the index of the weekly abstracts for the 2012.

                      Comment

                      Working...
                      X